Stimcell Energetics (STME) Total Debt Growth (1y) (2012 - 2023)
Stimcell Energetics (STME) Total Debt Growth (1y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 142.67% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -9.88% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1,188.16% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.12% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -17.79% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -9.03% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -0.50% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2023 | -53.01% |
| Aug 31, 2023 | 51.44% |
| May 31, 2023 | 49.35% |
| Feb 28, 2023 | -90.20% |
| Nov 30, 2022 | -91.75% |
| Aug 31, 2022 | -90.93% |
| May 31, 2022 | -88.00% |
| Feb 28, 2022 | -4.26% |
| Nov 30, 2021 | -1.44% |
| Aug 31, 2021 | -5.71% |
| May 31, 2021 | 25.47% |
| Feb 28, 2021 | 132.06% |
| Nov 30, 2020 | 127.99% |
| Aug 31, 2020 | 227.64% |
| May 31, 2020 | -17.79% |
| Feb 29, 2020 | 78.92% |
| Nov 30, 2019 | 68.15% |
| Aug 31, 2019 | 13.89% |
| May 31, 2019 | 98.20% |
| Feb 28, 2019 | 23.60% |